ID
VRTX icon

Integral Derivatives’s Vertex Pharmaceuticals VRTX Stock Holding History

Integral Derivatives’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		$293K Sell
1,800
-3,200
-64% -$523K 0.01% 514
2017
Q4 		$749K Sell
5,000
-8,000
-62% -$1.18M 0.01% 582
2017
Q3 		$1.98M Buy
13,000
+1,400
+12% +$211K 0.04% 314
2017
Q2 		$1.5M Buy
11,600
+6,100
+111% +$734K 0.03% 375
2017
Q1 		$601K Buy
+5,500
New +$484K 0.01% 692
2015
Q1 		– Sell
-2,200
Closed -$261K – 1411
2014
Q4 		$261K Hold
2,200
– – ﹤0.01% 1143
2014
Q3 		$247K Buy
+2,200
New +$209K ﹤0.01% 1209
2014
Q1 		– Sell
-21,000
Closed -$1.56M – 1603
2013
Q4 		$1.56M Buy
+21,000
New +$1.46M 0.02% 604

Other funds holding VRTX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return